IAPP and early-onset autosomal dominant Alzheimer disease: More recent studies show that long‐term peripheral amylin treatment enriched learning and memory in mouse models of Alzheimer's disease (Zhu et al. 2015; Qiu 2017; Zhu et al. 2017), suggesting amylin receptors as a drug target for potential treatment of the disease (Qiu 2017).